Objective. Women veterans with chronic pain utilize health care with greater frequency than their male counterparts. However, little is known about gender differences in the use of specialty pain care in this population. This investigation examined gender differences in self-reported use of opioids, interventional pain treatments, rehabilitation therapies, and complementary and integrative health (CIH) services for chronic pain treatment both within and outside of the Veterans Health Administration in a sample of veterans who served in support of recent conflicts.
Introduction
Chronic musculoskeletal pain (CMP) ranks as one of the most common conditions endorsed by men and women veterans who served in support of recent conflicts in Iraq and Afghanistan. Greater than 60% of those receiving care in Veterans Health Administration (VHA) facilities are diagnosed with one or more CMP conditions [1] . Women veterans are more likely than men to be diagnosed with CMP conditions in the first year following return from deployment [2] . When followed over a period of seven years, prevalence rates of musculoskeletal pain diagnoses increase more rapidly for women veterans relative to men [2] and women veterans with CMP are more likely to report pain of moderate/severe intensity [3] . Women veterans also utilize significantly more outpatient health care services in general and pain care services in particular [4] . Despite these observations, recent unpublished survey data reveal that women veterans are less satisfied with their pain care than men [5] . Additional findings from the Institute of Medicine's report Relieving Pain in America suggest that women with pain may experience more stigma from medical professionals, are at greater risk for misdiagnosis and suboptimal treatment, and evidence longer time to pain diagnosis relative to men [6] .
A growing number of studies have examined gender differences in receipt of pain care, particularly among civilians. Given the long-term risks associated with some pain treatment approaches, most research to date has focused on pharmacological treatments, opioids in particular. The civilian literature suggests that female patients may be more apt to receive opioid medications [7, 8] . Still, other civilian research suggests that differences in receipt of opioid medication among men and women may be influenced by physician gender, patient gender, and the physician/patient gender interaction [9] . In addition to medications, pain treatments like surgical interventions and interventional techniques are not uncommon, and the latter in particular are on the rise [10] [11] [12] [13] . At least one civilian study has demonstrated that women with osteoarthritis were less likely than men to undergo surgical interventions, particularly if they are elective [14] . This is consistent with broader research suggesting that compared with men, women tend to receive fewer costly health care interventions and may be less likely to receive surgical recommendations [15] . Few, if any, studies have examined gender differences in use of interventional procedures for pain. Nonpharmacologic treatments such as physical therapy and complementary and integrative health (CIH) approaches have received attention in recent years as acceptable, effective interventions for pain [16] [17] [18] [19] . Studies reporting on civilian samples suggest that women are more likely than men to elect CIH modalities in both a large national health survey [20] and among a primary care sample receiving opioids [21] .
As the number of women in military service and women veterans continues to grow, it is important to identify and address potential gender differences in preferences for and use of pain management services both within and outside of the Veterans Health Administration (VHA). To date, most investigations have examined gender differences in the use of pain care services within the VHA or within the Department of Defense. In these samples, apparent differences between civilian and military servicemember and veteran samples have begun to emerge. For example, in contrast to findings from studies of civilian samples, studies have documented that women veterans who served in support of the conflicts in Iraq and Afghanistan were less likely to receive long-term (90 days) opioid management relative to men [22] . Oliva and colleagues recently reported that among veterans seeking care in VHA settings who received long-term opioid therapy from 2010 to 2011, women were more likely than men to receive guideline-recommended care (e.g., mental health assessments, psychotherapy, rehabilitation therapy, and pharmacy reconciliation), though rates of concordance remained at or well below 50% on almost every measure [23] . However, this same report documented that women veterans enrolled in VHA care were also more likely to receive risky coprescriptions of opioids and sedatives [23] .
Consistent with the recommendations of the Institute of Medicine report and longstanding views from the broader pain management expert community, VHA policy guidance has encouraged a multimodal and interdisciplinary approach to chronic pain management, including nonopioid pharmacologic, interventional, and nonpharmacologic modalities such as rehabilitation medicine, behavioral, and CIH approaches [24] . Research suggests that women veterans with pain who use VHA care have a 67% higher rate of physical therapy visits relative to their male counterparts [4] . Turning attention to CIH use, among a large sample of active duty personnel serving in the Navy and Marine Corps, women were more than twice as likely to report engaging these modalities [25] . In the two studies examining CIH in veterans under VHA care, women were equally likely as men to use CIH when CIH was defined as herbal supplements, chiropractic care, acupuncture, and massage [26, 27] . However, women were underrepresented in these investigations and studies may not have been adequately powered to detect gender differences. To our knowledge, no studies have examined differences in use of nonopioid pharmacologic or interventional pain treatments (e.g., surgery, injections) among men and women veterans.
While interesting and potentially important, existing findings report only on care being accessed within the VHA and therefore cannot be generalized to the larger population of veterans. Though many veterans enrolled for VHA care use it exclusively, a significant proportion also use non-VHA private or community-based services. This is especially true of women veterans whose unique needs have historically warranted care from sources outside VHA [28] . The objective of the present investigation is to examine the use of pain treatments (opioid prescriptions, surgical/interventional pain treatments, rehabilitation therapy, and CIH) as a function of gender among veterans who served in support of recent wars and who reported chronic pain. Perhaps even more important, the current investigation aims to characterize these potential differences using a registry of veterans who enrolled in VHA care that examined self-reported use of pain treatment modalities regardless of setting (e.g., VHA, community) or source of payment. It was hypothesized that women veterans with CMP would report less use of opioids and surgical/interventional pain treatments relative to men, but greater use of rehabilitation therapies and CIH.
Method
Design Data for the current study were derived from the Women Veterans Cohort Study (WVCS) [3, [29] [30] [31] The present study reports on analyses of prospective survey data collected from a subsample of veterans included in the WVCS cohort identified from the OEF/ OIF/OND roster. Initially, letters were sent to a convenience sample of OEF/OIF/OND veterans who had enrolled in care at the Connecticut VA Healthcare System (Station 689) and the Indianapolis Healthcare System (Station 583); funding constraints limited recruitment beyond these regions. Veterans were not required to be exclusive users of VHA care. Letters described the study and invited veterans to return a prepaid card indicating whether they had interest in participating or not. Those who indicated interest were contacted by research personnel to be screened for eligibility (ability to read/write/speak English; verbal confirmation of OEF/ OIF/OND service). If interested and eligible, veterans consented and completed the survey in person at the respective medical center. Because this process was cumbersome and involved travel to the medical center, permission to obtain remote consent was later granted by the Institutional Review Board. Recruitment was then expanded to include veterans from the remaining five New England states as well as parts of Illinois and Indiana. Altogether, letters were sent to all OEF/OIF/ OND women veterans in these geographic regions (N ¼ 3,251 and 5,097 men). Veterans were given the option to complete the survey via pen/paper or via a Trial DB web interface. Altogether 767 veterans provided informed consent. Of these, 662 completed the survey between July 2008 and December 2011 (364 females, 298 males); women had a significantly higher response rate (11%) vs males (5.8%). Respondents were paid $20 following completion of the survey. Surveys assessed deployment/military service, health care utilization, lifestyle/health behaviors, and general health with a specific focus on pain, mental health, and stress. As highlighted previously, the study was approved by the Institutional Review Boards at the VA Connecticut Healthcare System, the Roudebush VA Healthcare System, and the Yale School of Medicine.
Participants
The present investigation reports on data from the subgroup of veterans who completed the first of three surveys spaced approximately one year apart. Among the original 662 survey respondents, 480 veterans endorsed "having any health problems or concerns related to their deployment." Of these, 377 (202 women, 175 men) endorsed "muscle aches," "swollen, stiff or painful joints," and/or "back pain" related to their deployment. The sample was further refined to include only those veterans who endorsed pain of three months' duration or longer (N ¼ 325, 175 women, 150 men). These veterans were all enrolled in VHA health care but were not necessarily exclusive users.
Measures

Dependent Variables
Pain Treatments. Respondents were asked to indicate the specific treatments they had used for their pain in the previous year. This includes services received within VHA, those received in the community, and services received within the Department of Defense (DoD) for those who were active duty during the prior year. Veterans were asked to self-report use of intervention modalities specifically to treat their pain by answering several "yes or no" questions from a structured list of treatment options included in the survey though veterans had the option to write in additional services. The decision to collapse treatments into one of the four different categories reflecting 1) opioid medication use, 2) interventional pain treatments, 3) rehabilitative interventions, and 4) CIH was made to ensure the most parsimonious interpretation of the data, to be consistent with groupings used in prior investigations and to avoid spurious associations.
Opioid Medications. Those veterans who reported using any of the following prescription opioid medications in the past week were classified as opioid medication users: morphine, oxycodone, hydrocodone, methadone, fentanyl, codeine, or propoxyphene. in joint, tendon, or bursa" during the prior year were classified as having received interventional pain treatment. Because so few veterans self-reported use of surgical interventions (12 women, 14 men), these individuals were also classified as having received interventional pain treatment.
Pain Rehabilitation Therapy. Veterans who endorsed utilizing "physical therapy" or receiving the following assistive devices, "braces, splints, orthotics, or prosthetics," to treat their pain in the prior year were classified as having received pain rehabilitation therapy.
Complementary and Integrative Health. Respondents who endorsed utilizing acupuncture, chiropractic, or massage services to address pain in the previous year were classified as CIH users.
Deployment and Demographic Variables
Deployment-Related Descriptive Variables. Number and location of deployments were obtained via survey responses. Duration of deployment was calculated by subtracting the most recent deployment start date from the most recent deployment end date; dates were extracted from the OEF/OIF/OND roster. Time since deployment to enrollment in VHA care was calculated by subtracting the most recent deployment end date from the first VHA observation date. Similarly, participation in baseline survey was calculated by subtracting the most recent deployment end date from the survey start date. Respondents reported their military occupational specialities (MOS), and these were coded into occupational categories using the Department of Defense Occupational Conversion Index (DoD 1312.1-1) [32] . These categories include combat specialists, electronic repair, communications/intelligence, health care, other technical specialists, functional support, electrical/ mechanical repair, craftworkers, and service/supply.
Demographics. Respondents reported age and gender. Race and personal income were assessed via checklist. The former was dichotomized into white vs minority status, and the latter was collapsed to reflect whether the individual made more or less than $25,000 per year in personal income. Respondents were also asked to rate whether they received service-connected disability income from the VHA by recording the percentage of the rating (0-100%). To assess access to care, respondents were asked to indicate how strongly they agreed with the following statement, "I have easy access to the medical specialists I need," using a 1 to 5 Likert scale where 1 represented "strongly agree" and 5 represented "strongly disagree."
Clinical Variables
Pain Severity. Pain severity was assessed by averaging the four pain severity items from the Brief Pain Inventory-Short Form (worst, least, average, and current pain; 0 to 10 scale, with higher values indicating more severe pain), which is a self-report measure developed to assess the severity of pain and its impact on daily functioning. This is a well-validated measure of pain severity [33] .
Number of Pain Conditions. Respondents were asked to indicate the following: "In the past three months, did you have any of the following: back pain, neck pain, headache or migraine, joint pain in your arms/hands/ legs/feet, facial ache or pain." The number of pain conditions was calculated by summing the number of endorsed painful conditions reported by participants.
Physical Health. Respondents completed the Veterans RAND 12 Item Health Survey (VR-12). The VR-12 was developed from the Veterans RAND 36 Item Health Survey (VR-36), which was developed from the MOS RAND SF-36 version 1.0 [34] . Given that the physical health component score is based partly on pain, only the initial question assessing self-rated health was included to avoid collinearity with the pain severity variable. Consistent with the literature on self-rated health in veterans, the variable was dichotomized into two categories, fair/poor and good/very good/excellent [35, 36] .
Mental Health. Respondents completed the PTSD Checklist-Military Version (PCL-M) [37] and the Physician Health Questionnaire 9 (PHQ-9) [38] to assess symptoms of PTSD and depression. Respondents were classified as having a probable mental health condition if they scored 45 or higher on the PCL-M or if they responded affirmatively to questions 1 or 2 of the PHQ-9 and affirmatively to two or more of the remaining PHQ-9 questions. These algorithms are indicators of probable PTSD and depression [39, 40] .
Data Analysis
Descriptive statistics were calculated to characterize the sample. Chi-square and t tests were applied, as appropriate, to examine gender differences in deploymentrelated, demographic, and clinical variables, along with reported use of pain treatments. Multivariable logistic regression models tested for associations between gender and pain treatments. All models were adjusted for age, race, personal income, service connection rating, perceived access to specialty care, presence of mental health disorder, self-rated health, pain severity, and number of pain conditions. Because most variables had some missing data (between 1% and 4%), models were estimated using multiple imputation. We generated 20 imputed data sets under a missing-at-random assumption (using the aregImpute function within the Hmisc package in the statistical software R), separately analyzed each imputed data set, and then combined results across imputations using Rubin's rules. We report imputed results (adjusted odds ratios and their 95% confidence intervals) [41, 42] .
Results
Of the 662 Veterans who completed the WVCS survey, all but nine were deployed in service of OEF/OIF/OND. Notably, of the 480 veterans who reported any deployment-related health concerns, men were statistically more likely to report having musculoskeletal disorders (MSD; 85% of men, 77% of women, p ¼ 0.05). Among the 377 men and women endorsing deployment-related MSD, 325 (175 women, 150 men) endorsed pain of three months' duration or longer (chronic pain) and were therefore queried about their experiences accessing specialty medical care and use of pain treatments. No gender differences in rates of self-reported chronic pain were observed (P ¼ 0.47).
Sample Characteristics
Among those with MSD and chronic pain (N ¼ 325), 54% reported being deployed only once in support of OEF/OIF/OND. An additional 35% reported a second deployment in support of these operations, and 10% reported three or more OEF/OIF/OND deployments. A small number of respondents reported deployments in support of operations elsewhere in the world. Men were statistically more likely to report a greater number of deployments (men ¼ 2.78, SD ¼ 2.06, women 2.1, SD ¼ 1.39). The average duration of the most recent deployment was 240 days (SD ¼ 120.89), and this did not vary by gender. The average time between enrollment in VHA health care and return from last deployment was 346 days (SD ¼ 413.46); women waited longer to initiate VHA services (398 days) relative to men (281 days). Overall, 70% enrolled for VHA care within one year of return; as highlighted previously, enrollment does not reflect exclusive or even regular use of VHA health care services. The average time that elapsed between end of last deployment and completion of the baseline survey was 3.86 years (1,409.97 days, SD ¼ 761.97), and this did not vary by gender. Deployment-related occupational specialties varied widely within the sample, with the largest representation in functional support (21%), service and supply (18%), electrical/mechanical repair (14%), combat specialty services (18%), and health care (11%). Please refer to Table 1 for deployment-related, demographic, and clinical characteristics of the sample. Overall, the sample was 81% white, and the majority, 64%, reported a personal income greater than $25,000. On average, pain was mild (M ¼ 3.80, SD ¼ 1.89); 168 respondents (52%) reported mild pain (<4/10). An additional 136 (40%) reported moderate pain (4-7/10), and only 19 respondents reported severe pain (>7). It is notable that 19% of women and 24% of men reported use of opioids, usually employed for management of moderate to severe pain. Forty-six percent endorsed symptoms consistent with a probable mental health condition. Finally, 64% of the sample believed they had "easy access to specialists." Women were younger on average than men (32.17 years vs 34.71 years, respectively, P ¼ 0.03), had a lower average VHA disability rating (29.17% vs 36.96%, respectively, P ¼ 0.02), self-reported a greater number of pain condtions (3.30 vs 2.94, P ¼ 0.00), and were more likely to self-report their health to be good/ very good/excellent (68% women, 57% men, P ¼ 0.05). Women and men did not differ significantly in terms of race, personal income, access to specialists, presence of mental health disorder, or pain severity (Ps > 0.05).
Gender Differences in Self-Reported Use of Pain Treatment Modalities
Bivariate chi-square analysis revealed that there were no unadjusted gender differences in reported use of any of the pain treatment modalities (Ps > 0.05), though there was a trend toward significance suggesting women were more likely to report use of CIH (P ¼ 0.09) (see Table 2 ).
Multivariable Logistic Regression: Gender and SelfReported Pain Treatment Modalities
Results of the multivariable logistic regression analyses of the multiply imputed data are presented in Table 3 . Models were run including deployment-related variables, but key estimates of gender did not change. Consequently, these variables were dropped from the final models.
Opioid Medications
After adjusting for covariates, there was no signficant gender difference in opioid use reporting (AOR ¼ 1.30, 95% CI ¼ 0.67-2.53, P ¼ 0.45). Veterans with higher service connection ratings (AOR ¼ 1.01, 95% CI ¼ 1.00-1.02), those in poorer health (AOR ¼ 0.46, 95% CI ¼ 0.24-0.91), and those with greater pain severity (AOR ¼ 1.36, 95% CI ¼ 1.11-1.35) had higher odds of reporting opioid medication use.
Interventional Pain Treatment
There were no statistically significant differences in reported use of interventional pain treatments by gender (AOR ¼ 0.65, 95% CI ¼ 0.36-1.16, P ¼ 0.14). Those who were older (AOR ¼ 1.03, 95% CI ¼ 1.00-1.05), who reported greater pain severity (AOR ¼ 1.25, 95% CI ¼ 1.05-1.59), and who reported poorer health (AOR ¼ 0.48, 95% CI ¼ 0.26-0.90) were more likely to report use of interventional pain treatments.
Pain Rehabilitation Therapy
Gender was not a significant independent predictor of pain rehabilitation service use (AOR ¼ 0.90, 95% CI ¼ 0.55-1.48, P ¼ 0.69). Analyses showed that not having a mental health diagnosis (AOR ¼ 0.48, 95% CI ¼ 0.26-0.86), greater pain severity (AOR ¼ 1.25, 95% CI ¼ 1.07-1.47), and more pain conditions (AOR ¼ 1.29, 95% CI ¼ 1.05-1.59) were associated with increased reported use of pain rehabilitation services.
Complementary and Integrative Health
Gender was not significantly associated with selfreported CIH use after controlling for potentially 
Discussion
More than two-thirds of the 662 veterans who completed the survey reported a deployment-related health concern (N ¼ 480). Among these individuals, men were statistically more likely than women to report persistent MSD related to deployment (85% men, 77% women), but there were no statistical differences in the percentages of men and women with these conditions who also reported chronic pain. Findings are inconsistent with research suggesting that male veterans are more likely than their female counterparts to report persistent pain one year after deployment [3] . They also stand in contrast to literature documenting greater likelihood of receiving an MSD diagnosis among women veterans each year following deployment [2] . In the current sample, veterans were asked to specify whether their condition was attributable to their deployment. By contrast, the investigation by Haskell and colleagues examined diagnostic codes that appeared in the electronic health record following deployment, but there was no way to know whether these MSDs were directly attributable to deployment. Although a great deal of attention has been focused on characterizing the experience of chronic pain among veterans, most investigations do not discriminate among painful conditions associated with deployment and painful conditions resulting from other causes or at other times. These findings suggest that a substantial number of veterans who served in support of recent conflicts report persistent MSD concerns that they attribute specifically to their deployment and, of these, an overwhelming majority report pain that is chronic. These findings support continued focus on pain care as a priority for both men and women.
Data from this survey suggest that, at least among OEF/OIF/OND veterans with MSD and chronic pain, there was evidence that a majority believed that they had "easy access to medical specialists." At the same time, there is a hint that women veterans, relative to men, from this cohort, experienced more challenges accessing specialty care. Moreover, there is evidence that a large proportion of veterans with diagnosed MSD and chronic pain have accessed specialty pain care, especially rehabilitation therapies and CIH approaches within the year prior to the survey. It is not possible, given the confines of the current data, to ascertain where this care was secured or whether there were gender differences in use of VHA care vs other sources. Veterans may have received reported care from community sources, the Department of Defense, or the VHA. Regardless of where the care is received, it is promising to note that the data generally suggest good access to and use of specialty pain care regardless of gender.
Contrary to hypotheses, although women veterans were marginally more likely to report use of interventional pain treatment and CIH in the past year, no statistically significant gender differences in self-reported use of specific pain treatments were noted in the current sample. There were no clear gender differences in self-report use of opioids, interventional pain treatments, rehabilitation therapy, or CIH to address pain after controlling for salient covariates.
Current findings appear to contradict recent research suggesting that women veterans were less likely to receive long-term (90 days) opioid management from the VHA relative to men [22] . However, it must be stated that the current data do not distinguish between long-and short-term opioid management; respondents reported on any use of opioids in the recent past rather than on long-term use. Moreover, current data do not distinguish between opioids prescribed within the VHA vs prescriptions obtained from the community.
Similarly, although there are no published investigations examining gender differences in the use of interventional treatments for pain among veterans, findings from the civilian literature suggest that women may be less likely to receive surgical recommendations, and when they do, they are less likely to elect to have them [43] . Notably, much of the literature reporting on gender differences in interventions for pain is focused on older Bold values denote significance (P < 0.05).
persons with arthritis. By contrast, the current sample is much younger. Thus, cohort effects may be driving the observed differences between the present findings and those in the extant literature. Indeed, findings from a sample of women veterans with pain who utilize VHA primary care have suggested that despite comparable pain intensity levels, women in the oldest cohort (age > 66 years) self-reported using fewer modalities to address their pain [44] .
Findings further appear to contrast extant literature suggesting that rehabilitation therapy is more common among women veterans utilizing VHA care [45] . As was the case with interventional modalities, there is a large difference in the average age of the veterans in the present study vs those in the study by Weimer and colleagues. Thus, findings may not be directly comparable. Of additional relevance, Kaur and colleagues (2007) revealed that women veterans with pain utilized 67% more physical therapy than men [4] . However, it's important to note that the former investigation reported on frequency of use (number of visits) while the current investigation reports the overall use of specific treatment modalities for pain. It is possible that men and women veterans are equally likely to utilize rehabilitative interventions but that women use them with greater intensity/frequency.
Current results also seem to contradict findings suggesting that among active duty personnel in the Navy and Marine Corps, women were more likely to report using CIH [25] . Results of the current analysis were, however, consistent with data suggesting that, among veterans using VHA care, no gender differences in use of CIH were detected [26, 27] . Unlike these two former studies, which included a small proportion of women, the current investigation oversampled women.
Overall, 57% of the sample reported using CIH. A 2006 investigation examining CIH use among veterans seen in a VHA pain clinic revealed that 31% reported electing this type of care [46] . As has been highlighted previously, the restricted age of the veterans in this sample may account for these differences. Indeed, veteran and civilian literatures, alike, suggest that middle-aged adults are most likely to use this modality [47] . Furthermore, the current data were collected between 2008 and 2011. In the time that elapsed between this investigation and the one published in 2006, the availability and uptake of CIH modalities within and outside the VHA system escalated. A more recent study (2011) of 401 VHA primary care patients with chronic pain revealed that 82% endorsed using one or more CIH modalities in the prior year. Of note, these researchers included the use of herbal medicines in their CIH classification, which is a departure from the current methodology [26] .
There are several possible explanations for apparent differences with prior observations. First, it may be that variations in the characteristics of the sample and the sampling methodology are important. Although a convenience sample of OEF/OIF/OND veterans, the current sample was not "treatment seeking" and was recruited largely independent of their interactions with the VHA. As already emphasized, this sample is also relatively young. Of particular importance may be that the sample was limited to those reporting MSD and chronic pain attributed to military deployment. Indeed, given that inclusion criteria required that MSD be related to deployment, rates of these conditions were substantially lower than the rates presented in the DoD Defense Manpower analysis reports. Still, the number of veterans reporting persistent MSD problems related to deployment almost four years after returning home is notable in this sample [1] . Still, the sample is small. The relatively large confidence intervals identified in analyses suggest that the study may have been underpowered to detect gender differences for some outcomes. Of further significance, the current study captures use of pain specialty services both within and outside of the VHA. Given that women veterans are more likely to be dual users of care, the current study may more accurately reflect utilization of these services relative to studies capturing VHA care alone [28] .
Though gender differences in the proclivity to use treatment modalities to address pain were not statistically significant, it is notable that approximately 21% of the sample reported use of an opioid, 27% reported use of interventional pain treatments, 59% reported use of rehabilitation therapy, and 57% reported use of CIH. These high overall rates of use of specialty pain care services are entirely consistent with a large and growing epidemiological literature that documents high and escalating costs of care associated with chronic pain [6, 48, 49] . The rates with which this sample endorsed using specialty pain treatment modalities are especially notable given the young average age. It might also be noted that estimates of the use of these services are likely conservative as the survey only sampled a limited number of interventional, rehabilitation, and CIH approaches. Results of this study and previously published literature with veterans receiving pain care in the VHA suggests the need to plan for high rates of pain specialty care, especially rehabilitation and CIH approaches, as this cohort ages.
It is interesting and perhaps encouraging to note that the percentage of veterans pursuing more conservative and relatively low-risk rehabilitation therapies and CIH approaches is substantially higher than those reporting the use of potentially risky pain medications and relatively expensive and potentially risky procedures, including interventional pain medicine approaches and surgery. These results could be viewed as consistent with the VHA's stepped care model of pain management, clinical practice guidelines, and standards for use of opioid therapy for the management of chronic pain and the use of interventional pain management approaches. This care model encourages use of less intensive and more conservative pain management approaches before escalating to more intensive and aggressive approaches [24, 50] .
Limitations of the current study include the use of cross-sectional data along with limited information about the frequency with which the respective modalities were used. The small sample size is also problematic, which may limit generalizability to the larger population of veterans with deployment-related pain. Additionally, the survey response rate was rather low-less than 10%; consequently, findings may not generalize to the larger cohort of OEF/OIF/OND veterans. Indeed, prior survey research with a similar cohort and with a similar monetary incentive had a response rate of 28% and revealed that younger veterans, those of minority status, and those with lower educational attainment were underrepresented, while reservists and those who had been deployed were overrepresented [51] . The lower observed rate in the current research relative to this prior study may stem from the initial requirement that veterans be consented in person. It is worth noting that the data are comprised of self-report responses to a survey as opposed to data from the electronic health record or other data sources that document actual service utilization. However, evidence from a prior investigation revealing good to excellent concordance between self-report and registered health care use suggests this is not likely to be a limiting factor [52] . The data from this study are also limited in that they do not necessarily reflect the extent of use of specific pain management services but only capture whether each category of service was used or not. It may be that women veterans are more likely than their male counterparts to more extensively or intensively use services in which they become engaged (e.g., more extensive participation in physical therapy or chiropractic care). Furthermore, there is no way to determine whether pain modalities were accessed within the VHA health care system, outside the VHA health care setting, or in both settings. Consequently, conclusions about gender differences in the frequency with which veterans use pain care modalities and in which setting are beyond the scope of this investigation.
